Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"Vasculogenic Mimicry"”.
-
Targeting Vasculogenic Mimicry in Cancer
… mechanism to angiogenesis known as vascular mimicry (VM). In VM capable tumours, pseudo blood vessels are formed by tumour cells that have acquired endothelial-like properties independently of host endothelium. VM is a marker of poor prognosis and metastasis in patients, however it is still …
-
Exploring vasculogenic mimicry and anti-angiogenic therapy resistance within breast cancer patient-derived tissue xenograft models
… which may be involved in causing AAT resistance. Vasculogenic mimicry (VM) is a unique non- angiogenic vascularisation method whereby tumour cells acquire endothelial cell-like characteristics and create tumour-lined pseudo-blood vessels. VM has been associated with poor prognosis, metastasis and …
-
Vasculogenic mimicry in bladder cancer and its association with cancer stem cells and human chorionic gonadotropin-beta
… and hence can invade and metastasise. Vascular mimicry is the process of formation of tumour cell lined channels for nutrient transportation, independent of typical modes of angiogenesis. However, not much research has been done to investigate the occurrence of vascular mimicry (VM) in bladder …
-
Development and application of an imaging and spatially-driven toolkit to elucidate vasculogenic mimicry in breast cancer mouse models
Vasculogenic mimicry (VM) is one form of tumour vascularisation that describes tumour cells that have acquired endothelial-like features, endowing them with the ability to form vessel-like structures. VM networks have been postulated to be functional, enabling them to play a critical role tumour …
-
Development and evaluation of methodologies for analysis of CTC and ctDNA in patients with ovarian carcinoma
… that epithelial to mesenchymal plasticity and vasculogenic mimicry plays in OC and its relationship with PD-L1 expression. In addition, ctDNA was analysed in 58 patients with high grade serous ovarian cancer (HGSOC) enrolled in a neoadjuvant chemotherapy (NACT) plus immune checkpoint inhibitor …